16283-36-6
CAS 16283-36-6
16283-36-6 (CAS 16283-36-6) is a pharmaceutical compound with 0 bioactivity targets and 69 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is 16283-36-6 used for in pharmaceutical contexts?
16283-36-6 (CAS 16283-36-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for 16283-36-6?
16283-36-6 has 69 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Balance disorder, Blood calcium decreased, Cognitive disorder, Constipation, Creatinine renal clearance decreased. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is 16283-36-6 also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for ZINC SALICYLATE with EU status "restricted".
What clinical phase is 16283-36-6 in?
No phase 1-4 clinical development badge is rendered for 16283-36-6 because the matched compound identifier rows do not contain a max-phase value.